Athanasios Pseftogas

4PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 08, 2026
The deubiquitinase activity of CYLD is required for B cell differentiation.

Athanasios Pseftogas, Jessica Bordini, George Gavriilidis

|Mar 18, 2025
Loss of CYLD promotes splenic marginal zone lymphoma.

Athanasios Pseftogas, Jessica Bordini, Silvia Heltai

|Oct 28, 2023
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency.

Nikolaos Bekas, Martina Samiotaki, Maria Papathanasiou

|Jul 02, 2020
HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.

Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis

Pageof 1